Јужноафричка Република -
Енглески -
South African Health Products Regulatory Authority (SAHPRA)
detrunorm« paed coated tablet
litha pharma (pty) ltd - coated tablet - not indicated - each tablet contains propiverine hydrochloride equivalent to propiverine 5,0 mg
Сингапур -
Енглески -
HSA (Health Sciences Authority)
dormicum injection 5 mg5 ml
dksh singapore pte. ltd. - midazolam - injection - 5 mg/5 ml - midazolam 1 mg/ml
Сингапур -
Енглески -
HSA (Health Sciences Authority)
dormicum tablet 7.5 mg
roche singapore pte. ltd. - midazolam maleate 10.2mg eqv. to midazolam - tablet, film coated - 7.5mg
Сингапур -
Енглески -
HSA (Health Sciences Authority)
dormicum injection 15 mg3 ml
dksh singapore pte. ltd. - midazolam - injection - 15 mg/3 ml - midazolam 5 mg/ml
Сингапур -
Енглески -
HSA (Health Sciences Authority)
dormicum tablet 15 mg
dksh singapore pte. ltd. - midazolam maleate 20.40 mg eqv. to midazolam - tablet, film coated - 15 mg - midazolam maleate 20.40 mg eqv. to midazolam 15 mg
Европска Унија -
Енглески -
EMA (European Medicines Agency)
lojuxta
amryt pharmaceuticals dac - lomitapide - hypercholesterolemia - lipid modifying agents - lojuxta is indicated as an adjunct to a low‑fat diet and other lipid‑lowering medicinal products with or without low-density-lipoprotein (ldl) apheresis in adult patients with homozygous familial hypercholesterolaemia (hofh). genetic confirmation of hofh should be obtained whenever possible. other forms of primary hyperlipoproteinaemia and secondary causes of hypercholesterolaemia (e.g. nephrotic syndrome, hypothyroidism) must be excluded.,
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
lojuxta 5mg capsules
amryt pharma - lomitapide - capsule - 5mg
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
lojuxta 10mg capsules
amryt pharma - lomitapide - capsule - 10mg
Велика Британија -
Енглески -
MHRA (Medicines & Healthcare Products Regulatory Agency)
lojuxta 20mg capsules
amryt pharma - lomitapide - capsule - 20mg
Израел -
Енглески -
Ministry of Health
lojuxta 10 mg
medison pharma ltd - lomitapide as mesylate - capsules - lomitapide as mesylate 10 mg - lomitapide - an adjunct to a low-fat diet and other lipid-lowering treatments, including ldl apheresis where available, to reduce low-density lipoprotein cholesterol (ldl-c), total cholesterol (tc), apolipoprotein b (apo b), and non-high-density lipoprotein cholesterol (non-hdl-c) in patients with homozygous familial hypercholesterolemia (hofh).